Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,816,000 | $2,761,000 | $2,652,000 | $2,621,000 |
| % Growth | 2% | 4.1% | 1.2% | – |
| Cost of Goods Sold | $1,867,000 | $1,818,000 | $1,789,000 | $1,763,000 |
| Gross Profit | $949,000 | $943,000 | $863,000 | $858,000 |
| % Margin | 33.7% | 34.2% | 32.5% | 32.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $501,000 | $486,000 | $476,000 | $466,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $62,000 | $19,000 | $41,000 | $31,000 |
| Operating Expenses | $563,000 | $505,000 | $517,000 | $497,000 |
| Operating Income | $386,000 | $438,000 | $346,000 | $361,000 |
| % Margin | 13.7% | 15.9% | 13% | 13.8% |
| Other Income/Exp. Net | -$50,000 | -$45,000 | -$52,000 | -$57,000 |
| Pre-Tax Income | $336,000 | $393,000 | $294,000 | $304,000 |
| Tax Expense | $77,000 | $97,000 | $59,000 | $68,000 |
| Net Income | $245,000 | $282,000 | $220,000 | $222,000 |
| % Margin | 8.7% | 10.2% | 8.3% | 8.5% |
| EPS | 2.18 | 2.51 | 1.97 | 1.98 |
| % Growth | -13.1% | 27.4% | -0.5% | – |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.95 |
| Weighted Avg Shares Out | 112,000 | 112,000 | 111,000 | 111,000 |
| Weighted Avg Shares Out Dil | 113,000 | 113,000 | 113,000 | 113,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,000 | $2,000 | $5,000 | $7,000 |
| Interest Expense | $69,000 | $69,000 | $72,000 | $72,000 |
| Depreciation & Amortization | $142,000 | $143,000 | $140,000 | $135,000 |
| EBITDA | $547,000 | $596,000 | $488,000 | $507,000 |
| % Margin | 19.4% | 21.6% | 18.4% | 19.3% |